3Grothey A, Goldberg RM.A review of oxaliplatin and its clinical use in colorectal cancer[J] .Expert Opin Pharmacother, 2004,5(10) : 2 159.
4Miyagi Y, Kawanishi K, Miyagi Y, et al .Cytocidal effect and DNA damage of nedaplatin:a mathematical model and analysis of experimental data[J] .Cancer Chem Pharmacol, 2001,47(3) : 229.
7McKeage MJ .Lobaplatin: a new antitumour platinum drug[J]. Expert Opin Investig Drugs, 2001,10(1) : 119.
8Kim DK, Kim HT, Cho YB, et al .Antitumor activity of cis-malonato[ (4R, 5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane] platinum(Ⅱ),a new platinum analogue,as an anticancer agent[J]. Cancer Chem Pharmacol, 1995,35(5) : 441.
9Min Y J, Bang SJ, Shin JW, et al . Combination chemotherapy with 5 - fluorouracil and heptaplatin as first- line treatment in patients with advanced gastric cancer[J] .J Korean Med Sci, 2004,19(3) :3 693.
10Kelland LR. An update on satraplatin: the first orally available platinum anticancer drug[J] .Expert Opin Investig Drugs, 2000,9(6):1 373.
3[1]Capizzi RL. Amifostine:the preclinical basis for broadspectrum selective cytoprotection of normal tissue from cytotoxic therapies [J]. Semin Oncol, 1996,23 (4supple 8):2-17.
4[2]Shuchter LM. Guidelines for the administration of amifostine [J]. Semin Oncol, 1996,23 (4 supple 8) : 40 -43.
5[3]Capizzi RL. The preclinical basis for broad-spectrum selective cytoprotect-ion of normal tissues form cytotoxic therapies by amifostine [J]. Semin Oncol, 1999,26(2 supple 7) :3-21.
7[5]Thomas Budd G. Amifostine and chemotherapy-relatedthrombocytoperia [J ]. Semin Oncol, 1996, 23 (4supple 8) :49-52.
8[6]Spencer CM ,Goa KL. Amifostine :a review of its pharmocodynamic and pharmokinetic properties ,and therapeutic potential as a radioprotector and cytotoxic chemoprotector [J]. Drug, 1995,50(6): 1001 - 1031.
9[7]Kemp G,Rose P,Lurain J,et al. Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer [J]. J Clin Oncol, 1996,14 : 2101 - 2112.
10[8]Bohuslavizki KH,Brennar W,Klutmann S,et al. Radioprotection of salivary glands by amifostine in highdose radioiodine therapy[J]. J Nul Med, 1998,39 (7):1237-1242.
